Dividend Information About McCormick: Everything You Need To Know Before Its Ex-Dividend Date on Oct 14, 2025
Generated by AI AgentAinvest Dividend Digest
Friday, Oct 10, 2025 7:59 pm ET1min read
MKC--
Aime Summary
McCormick & Company (MKC) has announced a cash dividend of $0.45000000 per share, marking a significant increase from the average of the last 10 dividends, which stood at $0.3167619. The ex-dividend date is set for Oct 14, 2025, meaning investors must hold shares before this date to qualify for the payout. The dividend will be distributed on Oct 27, 2025, following the announcement made on Sep 30, 2025. This is the second consecutive dividend of $0.45000000 per share, with the prior one issued on Jul 21, 2025. Investors should note that the ex-dividend date is the last day to purchase shares and still receive the upcoming dividend; any purchase after this date will not be eligible for the distribution.
Over the past week, McCormickMKC-- has been in the spotlight for several key developments that could influence its market performance. The company recently reaffirmed its strong sales growth but revised its 2025 profitability outlook due to rising commodity and tariff-related costs. Despite a better-than-expected third-quarter performance, with a gross profit margin of 37.4%, management has acknowledged ongoing margin pressures that could impact long-term growth. Analysts have noted that while the company’s global expansion into high-growth, health-oriented markets—particularly in the Asia-Pacific region—is broadening its addressable market, it is also facing headwinds from input cost inflation and weak demand from key customers.
Additionally, as of late, MKCMKC-- has seen a mix of analyst sentiment. Jefferies and J.P. Morgan have both maintained their Buy ratings, with the latter setting a price target of $79.00. However, the stock currently trades at a price-to-earnings ratio of 22.7x, which is above the industry average, raising questions about its valuation. Investors are closely watching whether the recent dip in share price, which has declined nearly 16% over the past year, reflects a potential undervaluation or a realistic assessment of future growth constraints.
Since the last update, MKC’s stock has shown moderate resilience, with a slight gain of +0.46% on Oct 7, 2025, following an earnings call where the company outlined its strategy to drive volume-led growth amid challenging market conditions. As the company continues to navigate trade pressures and cost inflation, its ability to sustain its recent momentum will be crucial in determining whether its optimistic fair value of $82.46 is achievable. Investors should remain cautious but attentive, as the balance between growth potential and margin pressures will shape the stock’s trajectory in the months ahead. The ex-dividend date of Oct 14, 2025, is the last day for investors to buy in and still receive the dividend of $0.45000000 per share.
Over the past week, McCormickMKC-- has been in the spotlight for several key developments that could influence its market performance. The company recently reaffirmed its strong sales growth but revised its 2025 profitability outlook due to rising commodity and tariff-related costs. Despite a better-than-expected third-quarter performance, with a gross profit margin of 37.4%, management has acknowledged ongoing margin pressures that could impact long-term growth. Analysts have noted that while the company’s global expansion into high-growth, health-oriented markets—particularly in the Asia-Pacific region—is broadening its addressable market, it is also facing headwinds from input cost inflation and weak demand from key customers.
Additionally, as of late, MKCMKC-- has seen a mix of analyst sentiment. Jefferies and J.P. Morgan have both maintained their Buy ratings, with the latter setting a price target of $79.00. However, the stock currently trades at a price-to-earnings ratio of 22.7x, which is above the industry average, raising questions about its valuation. Investors are closely watching whether the recent dip in share price, which has declined nearly 16% over the past year, reflects a potential undervaluation or a realistic assessment of future growth constraints.
Since the last update, MKC’s stock has shown moderate resilience, with a slight gain of +0.46% on Oct 7, 2025, following an earnings call where the company outlined its strategy to drive volume-led growth amid challenging market conditions. As the company continues to navigate trade pressures and cost inflation, its ability to sustain its recent momentum will be crucial in determining whether its optimistic fair value of $82.46 is achievable. Investors should remain cautious but attentive, as the balance between growth potential and margin pressures will shape the stock’s trajectory in the months ahead. The ex-dividend date of Oct 14, 2025, is the last day for investors to buy in and still receive the dividend of $0.45000000 per share.

Sip from the stream of US stock dividends. Your income play.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet